The Indian pharma sector showed modest downward pressure in early trading on January 14, 2026, as of approximately 9:55 AM IST. The S&P BSE Healthcare index was down around -0.37% at 43,242.84, while broader market benchmarks like the S&P BSE Sensex traded lower by -0.17% at 83,481.56 and the Nifty 50 edged up slightly by 0.04% at 25,742.45.
Pharma Stocks Performance (as of ~9:55 AM IST, January 14, 2026)
Here is a summary of the listed pharma stocks with their BSE and NSE prices and percentage changes:
- Aarti Drugs: BSE ₹392.60 (-0.30%), NSE ₹392.20 (-0.37%)
- Ajanta Pharma: BSE ₹2,688.70 (-1.54%), NSE ₹2,673.70 (-2.08%)
- Alembic Pharma: BSE ₹793.95 (-0.82%), NSE ₹793.80 (-0.91%)
- Aurobindo Pharma: BSE ₹1,168.70 (+0.14%), NSE ₹1,170.40 (+0.23%)
- Biocon: BSE ₹380.05 (+0.73%), NSE ₹381.40 (+1.09%)
- Cipla: BSE ₹1,429.90 (-1.22%), NSE ₹1,431.80 (-1.14%)
- Divi’s Laboratories: BSE ₹6,407.00 (-0.42%), NSE ₹6,423.00 (-0.21%)
- Dr. Reddy’s Lab: BSE ₹1,184.00 (-0.53%), NSE ₹1,186.80 (-0.38%)
- Glenmark Pharma: BSE ₹2,017.00 (+0.40%), NSE ₹2,018.00 (+0.49%)
- Indoco Remedies: BSE ₹217.80 (+1.23%), NSE ₹217.62 (+0.65%)
- Ipca Labs: BSE ₹1,490.45 (-1.08%), NSE ₹1,494.30 (-0.90%)
- J.B. Chemicals: BSE ₹1,852.85 (-0.78%), NSE ₹1,853.90 (-0.80%)
- Lupin: BSE ₹2,159.00 (-0.82%), NSE ₹2,156.90 (-1.01%)
- Mankind Pharma: BSE ₹2,209.05 (-0.18%), NSE ₹2,225.00 (+0.50%)
- Natco Pharma: BSE ₹878.15 (+1.00%), NSE ₹878.50 (+0.77%)
- Orchid Pharma: BSE ₹726.25 (-1.00%), NSE ₹728.90 (-1.29%)
- Panacea Biotec: BSE ₹395.40 (-0.44%), NSE ₹395.95 (-0.20%)
- Strides Pharma Science: BSE ₹925.10 (-0.27%), NSE ₹928.05 (+0.17%)
- Sudeep Pharma Ltd.: BSE ₹607.30 (-2.12%), NSE ₹609.95 (-1.84%)
- Sun Pharma: BSE ₹1,706.50 (-1.35%), NSE ₹1,707.90 (-1.20%) (Note: Recent live updates show Sun Pharma trading closer to ₹1,728-1,737 levels with minor intraday movement)
- Torrent Pharma: BSE ₹3,908.00 (-0.80%), NSE ₹3,910.20 (-0.76%)
- Wockhardt: BSE ₹1,404.85 (+1.23%), NSE ₹1,409.50 (+1.58%)
- Zydus Lifesciences: BSE ₹888.20 (-1.34%), NSE ₹888.05 (-1.40%)
Key Observations
- Most pharma stocks traded in the red, with declines ranging from mild (under -1%) to moderate (over -1-2%).
- A few counters showed gains, including Biocon (+0.73-1.09%), Indoco Remedies (+0.65-1.23%), Natco Pharma (+0.77-1.00%), Aurobindo Pharma (+0.14-0.23%), Glenmark Pharma (+0.40-0.49%), Wockhardt (+1.23-1.58%), and Strides Pharma Science (mixed).
- Larger players like Sun Pharma, Cipla, Divi’s Laboratories, and Zydus Lifesciences saw declines of around 0.2-1.35%.
- The sector underperformed relative to the flat-to-slightly positive Nifty 50 in the provided snapshot.
This data reflects early session levels; intraday movements can change based on broader market flows, global cues, and any sector-specific news. Investors should check real-time sources like NSE/BSE for the latest prices.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.